April 02, 2021
Although nearly 70% of the population cohort had conditions requiring medications, there was no increase in the number of reported adverse events while taking CBD products.
March 24, 2021
BioLyte Laboratories and Honest Globe have 15 days to rectify the violations from their CBD products.
March 15, 2021
In a presentation from APhA2021, clinical pharmacist Danielle Fixon, PharmD, BCGP, BCPS, offers counseling tips for CBD products.
January 25, 2021
Results of a study presented in a poster presentation during ASHP Midyear collected data of the available OTC CBD products being sold in Colorado pharmacies.
January 06, 2021
Survey results presented during the ASHP 2020 Midyear Clinical Meeting and Exhibition offered insight into community pharmacists’ knowledge and confidence of CBD products.
November 24, 2020
Although the booming demand can make CBD products a profitable addition to any pharmacy inventory, some questions remain about the legal compliance factors.
November 13, 2020
Tips for building financial success with CBD for your pharmacy.
November 12, 2020
As the use of CBD-containing products continues to rise, pharmacists need to be familiar with the clinical implications of CBD use, especially in patients who use other pharmacologically active substances.
November 09, 2020
What pharmacists need to consider before selling CBD in their stores.
October 26, 2020
By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.
October 21, 2020
CBD and its impacts on a protective peptide show that the cannabinoid may reduce lung inflammation and damage.
August 04, 2020
The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.
July 31, 2020
Our first episode of our latest Cannabis Series is focused on the burgeoning medical marijuana landscape, featuring FDA's guidelines and research on the diverse benefits of cannabis as medicine.
July 27, 2020
Responding to growing interest by industry stakeholders, the agency has offered draft guidance outlining quality considerations and other practical recommendations for cannabis and cannabis-derived compounds.
May 30, 2020
A systematic review of medical cannabis and cannabinoid use in oncology care demonstrated varied results.
April 07, 2020
Cannabidiol oral solution (Epidiolex, GW Pharmaceuticals) is no longer considered a controlled substance.
March 06, 2020
Strategies for seizing revenue opportunities outside of the PBM.
February 04, 2020
A supplemental application for cannabidiol oral solution (Epidiolex, GW Pharmaceuticals and Greenwich Biosciences) has been submitted for the treatment of seizures associated with tuberous sclerosis complex.
December 10, 2019
Takeaways from a roundtable at ASHP 2019.
November 26, 2019
The FDA issued warning letters to several companies marketing their CBD products in ways that violate the Federal Food, Drug, and Cosmetic Act.
